daclatasvir
chemical compound
Facts
13 properties- Instance of
- type of chemical entity
- Subclass of
- heterocyclic compound
- Has use
- medication
- Active ingredient in
- Daklinza
- Canonical SMILES
- CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
- Catalog
- CAS COVID-19 Anti-Viral Candidate Compounds
- Chemical formula
- C₄₀H₅₀N₈O₆
- Defined daily dose
- 60 mg
- Isomeric SMILES
- CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*
- Mass
- 738.385331 Da
- Medical condition treated
- hepatitis C, liver cirrhosis, hepatitis C (2015–present)
- Subject has role
- xenobiotic-transporting ATPase inhibitor, WHO essential medicines, bactericide, antiviral drug
🏷️ Also known as
en EBP 883
en N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester
en BMS 790052
en BMS-790052
en BMS790052
en daclatasvir
en Daclatasvir
en Daklinza
en Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate
ar داكلاتازفر
el ντακλατασβίρη
fa داکلاتاسویر
fi daklatasviiri
id Daklatasvir
ja ダクラタスビル
ru Даклатасвир
uk даклатасвір
zh 达卡他韦
zh 达拉他韦
🔖 Identifiers · 31
- OpenAlex ID
- C2776979040
- BabelNet ID
- 02950127n
- CAB ID
- 33890
- CAS Registry Number
- 1009119-64-5
- ChEBI ID
- 82977
- ChEMBL ID
- CHEMBL2023898
- ChemSpider ID
- 24609522
- DSSTox substance ID
- DTXSID901026404
- DrugBank ID
- DB09102
- DrugCentral ID
- 4875
- Electronic Essential Medicines List medicine ID
- 295
Show all 31 identifiers +19
- Freebase ID
- /m/0j_6hxg
- Guide to Pharmacology Ligand ID
- 11266
- InChIKey
- FKRSSPOQAMALKA-CUPIEXAXSA-N
- KEGG ID
- D10065
- LiverTox ID
- Daclatasvir
- MeSH descriptor ID
- C549273
- MedlinePlus drug identifier
- a615044
- Microsoft Academic ID (discontinued)
- 2776979040
- NDF-RT ID
- N0000191739
- Probes And Drugs ID
- PD011172
- PubChem CID
- 25154714
- Reaxys registry number
- 13077731
- RxNorm CUI
- 1606218
- UMLS CUI
- C3252090
- UNII
- LI2427F9CI
- UniChem compound ID
- 23797901
- WikiProjectMed ID
- Daclatasvir
🔗 Connections
Medical condition treated 3
Subject has role 3
← Drug or therapy used for treatment 2
Has use 1
Subclass of 1
Press Enter · cited answer in seconds
0 sources
Summary
daclatasvir is a type of chemical entity[1]. daclatasvir is a type of heterocyclic compound[2].
Key Facts
- Canonical SMILES: CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC[3]
- Chemical formula: C₄₀H₅₀N₈O₆[4]
- Has use: medication[5]
- Catalog: CAS COVID-19 Anti-Viral Candidate Compounds[6]
- Isomeric SMILES: CC(C)C@@HNC(=O)OCC@@HNC(=O)OC">[7]
- Mass: 738.385331 dalton[8]
- Medical condition treated: hepatitis C[9], liver cirrhosis[10]
- Subject has role: xenobiotic-transporting ATPase inhibitor[11], WHO essential medicines[12], bactericide[13], antiviral drug[14]
- Active ingredient in: Daklinza[15]
- Defined daily dose: 60 milligram[16]
- LiverTox likelihood score: LiverTox toxicity likelihood category E*[17]